Research and innovation
the future of testing with a dedicated hub
This division brings together deep expertise in physiology, cell biology, and microbiology, integrating this knowledge with the continuous adoption of new techniques and technologies.
Our research scope goes beyond assessing the biocompatibility of medical devices, chemicals, pharmaceuticals, and cosmetics—it also encompasses ensuring microbiological safety
This approach enables us to anticipate technological developments by designing innovative solutions. We are committed to creating and implementing ever more advanced methods, thus contributing to the constant improvement in quality, efficacy and safety of the products we research.
Driven by our commitment to scientific excellence, we continue to push the boundaries of research and innovation. Our ambition is to shape the future by offering solutions that meet the current and future needs of the medical, chemical and cosmetics industries.
The Icare Group is committed to Research & Innovation.
Innovation is at the core of the Icare Group’s mission, with two fundamental priorities, pursuing two fundamental priority objectives:
1. Development of alternative methods in line with the 3R rule (Replacement, Reduction, Refinement) for assessing the biocompatibility of Medical Devices
In our constant quest for improvement, we are committed to exploring and implementing innovative methods in line with the 3R principles. Replacement, reduction and refinement guide our approach, enabling more ethical, efficient and accurate biocompatibility assessment of medical devices.
2. Enhancing microbiological safety.
Microbiological safety is at the heart of our concerns. We aim to raise standards by developing advanced approaches and cutting-edge technologies to guarantee microbiological safety in a variety of fields, from medical devices to chemicals, pharmaceuticals and cosmetics.
Our approach to innovation is built upon several key pillars:
- Internal research programs
- National and international multidisciplinary collaborations
- Strategic technological advancements
By investing in strategic technological developments, we continuously strengthen our offerings.
